The Shea group investitages antigen-conjugated nanoparticle treatment

UM Invests in BI Startup Greenmark Biomedical

Posted on 22 Feb

UM Invests in BI Startup Greenmark Biomedical


GreenMark Biomedical, Inc., a startup developing starch-based biomaterials for targeted delivery for diagnosis and treatment of tooth decay, will receive $500K in investment from UM. This investment will be through UM’s Michigan Investment in New Technology Startups (MINTS) fund, which is overseen by the Investment Office.GreenMark Biomedical, Inc. holds an exclusive license to technologies that were developed by BI Director and Chemical Engineering Professor, Joerg Lahann.

 

Learn More about GreenMark

« Back to News

The Biointerfaces Institute brings extensive experience to the collaborations that lead to scientific breakthroughs, successful translation, and advanced learning.

Work With Us
a